Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The receptor activator of nuclear factor kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system plays a significant role in osteoclastogenesis, activation of osteoclasts, and regulation of bone resorption. This study aimed to evaluate the use of the salivary soluble RANKL (sRANKL)/OPG ratio as a diagnostic marker for periodontitis in nonsmokers. Methods: Twenty-five patients with chronic periodontitis and 25 individuals with a healthy periodontium were enrolled in this study. Samples containing 5 mL of unstimulated saliva were obtained from each subject. Salivary sRANKL and OPG concentrations were determined using a standard enzyme-linked immunosorbent assay. Statistical analysis was performed using SPSS ver. 18.0. Results: The levels of sRANKL and OPG were detectable in all of the samples. Positive relationships were found between the plaque index and clinical attachment level and both the salivary concentration of sRANKL and the salivary sRANKL/OPG ratio (P<0.05). The salivary concentration of sRANKL and the sRANKL/OPG ratio were significantly higher in the periodontitis group than in the healthy group (P=0.004 and P=0.001, respectively). In contrast, the OPG concentration showed no significant differences between the groups (P=0.455). Conclusions: These findings suggest that the salivary sRANKL/OPG ratio may be helpful in the screening and diagnosis of periodontitis. However, longitudinal studies with larger populations are needed to confirm these results.
Abstract
Purpose: The receptor activator of nuclear factor kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system plays a significant role in osteoclastogenesis, activation of osteoclasts, and regulation of bone resorption. This study aimed to evaluate the use of the salivary soluble RANKL (sRANKL)/OPG ratio as a diagnostic marker for periodontitis in nonsmokers. Methods: Twenty-five patients with chronic periodontitis and 25 individuals with a healthy periodontium were enrolled in this study. Samples containing 5 mL of unstimulated saliva were obtained from each subject. Salivary sRANKL and OPG concentrations were determined using a standard enzyme-linked immunosorbent assay. Statistical analysis was performed using SPSS ver. 18.0. Results: The levels of sRANKL and OPG were detectable in all of the samples. Positive relationships were found between the plaque index and clinical attachment level and both the salivary concentration of sRANKL and the salivary sRANKL/OPG ratio (P<0.05). The salivary concentration of sRANKL and the sRANKL/OPG ratio were significantly higher in the periodontitis group than in the healthy group (P=0.004 and P=0.001, respectively). In contrast, the OPG concentration showed no significant differences between the groups (P=0.455). Conclusions: These findings suggest that the salivary sRANKL/OPG ratio may be helpful in the screening and diagnosis of periodontitis. However, longitudinal studies with larger populations are needed to confirm these results.
참고문헌 (30)
- Genco RJ, "Current view of risk factors for periodontal diseases", J Periodontol, 67(10), pp.1041~1049 (1996)
- Giannobile WV, "Saliva as a diagnostic tool for periodontal disease : current state and future directions", Periodontol 2000, 50, pp.52~64 (2009)
- Sexton WM, "Salivary biomarkers of periodontal disease in response to treatment", J Clin Periodontol, 38, pp.434~441 (2011)
- Kaufman E, "Analysis of saliva for periodontal diagnosis : a review", J Clin Periodontol, 27, pp.453~465 (2000)
- Buduneli N, "Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis", J Clin Periodontol, 38(11), pp.85~105 (2011)
- Suda T, "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families", Endocr Rev, 20, pp.345~357 (1999)
- Yasuda H, "Osteoclast differentiation factor is a ligand for osteoprotegerin", osteoclastogenesis-inhibitory factor and is identical to TRANCE, Proc Natl Acad Sci U S A, pp.1998, 95[DOI]
- Quinn JM, "Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation", J Bone Miner Res, 15, pp.1459~1466 (2000)
- Horwood NJ, "Activated T lymphocytes support osteoclast formation in vitro", Biochem Biophys Res Commun, 265, pp.144~150 (1999)
- Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93, pp.165~176 (1998)
- Kong YY, "OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis", Nature, 397, pp.315~323 (1999)
- Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Vega D, "CLINICAL Review # : the role of receptor activator of nuclear factor-kappaB(RANK)", RANK ligand, J Clin Endocrinol Metab, pp.2007, 92[DOI]
- Crotti T, "Receptor activator NF kappaB ligand(RANKL)and osteoprotegerin(OPG)protein expression in periodontitis", J Periodontal Res, 38, pp.380~387 (2003)
- Mogi M, "Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis", J Dent Res, 83, pp.166~169 (2004)
- Vernal R, "Levels of cytokine receptor activator of nuclear factor kappaB ligand in gingival crevicular fluid in untreated chronic periodontitis patients", J Periodontol, 75, pp.1586~1591 (2004)
- Bostanci N, "Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases : implications of their relative ratio", J Clin Periodontol, 34, pp.370~376 (2007)
- Frodge BD, "Bone remodeling biomarkers of periodontal disease in saliva", J Periodontol, 79, pp.1913~1919 (2008)
- Miller CS, "Salivary biomarkers of existing periodontal disease : a cross-sectional study", J Am Dent Assoc, 137, pp.322~329 (2006)
- Costa PP, "Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes", J Periodontol, 81, pp.384~391 (2010)
- Al-Sabbagh M, "Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health", J Periodontal Res, 47, pp.389~395 (2012)
- Tobon-Arroyave SI, Isaza-Guzman DM, Restrepo-Cadavid EM, Zapata-Molina SM, Martinez-Pabon MC, "Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status", J Clin Periodontol 2012 ;, 39, pp.1132~1140
- Armitage GC, "Development of a classification system for periodontal diseases and conditions", Ann Periodontol, 4, pp.1~6 (1999)
- Silness J, "Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion", Acta Odontol Scand, 22, pp.121~135 (1964)
- Ainamo J, "Problems and proposals for recording gingivitis and plaque", Int Dent J, 25, pp.229~235 (1975)
- Navazesh M, "Methods for collecting saliva", Ann N Y Acad Sci, 694, pp.72~77 (1993)
- Kinney JS, "Oral fluid-based biomarkers of alveolar bone loss in periodontitis", Ann N Y Acad Sci, 1098, pp.230~251 (2007)
- Takayanagi H, "Inflammatory bone destruction and osteoimmunology", J Periodontal Res, 40, pp.287~293 (2005)
- Buduneli N, "Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients", J Clin Periodontol, 35, pp.846~852 (2008)
- Belibasakis GN, "The RANKL-OPG system in clinical periodontology", J Clin Periodontol, 39, pp.239~248 (2012)